Walgreens Boots Alliance, Inc.’s Stock Price Dips to $10.82, Marking a 3.91% Decrease: A Closer Look at WBA’s Market Performance

Walgreens Boots Alliance, Inc. (WBA)

10.82 USD -0.44 (-3.91%) Volume: 26.94M

Walgreens Boots Alliance, Inc.’s stock price currently stands at 10.82 USD, experiencing a decline of -3.91% in the latest trading session with a significant trading volume of 26.94M, reflecting a notable YTD percentage change of -58.56%, highlighting the underperformance of WBA stock in the current market.

Latest developments on Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance stock price faced a significant plunge in June, prompting questions about whether it is a wise investment choice. Despite this, Moloney Securities Asset Management LLC increased its stake in the company, while Sequoia Financial Advisors LLC reduced theirs. Conversely, the State of Alaska Department of Revenue sold 4000 shares of Walgreens Boots Alliance. HB Wealth Management LLC raised its holdings, and Van ECK Associates Corp now holds a $2.71 million stock position in the company. Norden Group LLC also made a new $1.52 million investment and bought 69,819 shares of Walgreens Boots Alliance. Additionally, Boots announced a store closure programme set to be completed by summer 2024, further impacting the company’s stock movements.

Walgreens Boots Alliance, Inc. on Smartkarma

Analysts on Smartkarma have been closely following Walgreens Boots Alliance, with reports from providers like Baptista Research and Travis Lundy shedding light on the company’s performance and future prospects. Baptista Research‘s analysis focuses on the company’s recent earnings report, highlighting the solid execution in the U.S. Retail Pharmacy segment and international performance. The report also delves into factors that could influence the company’s stock price in the near future, using a Discounted Cash Flow methodology for valuation.

On the other hand, Travis Lundy’s report discusses Walgreens Boots Alliance‘s removal from the Dow Jones Industrial Average and historical trends of companies that have been deleted from the index. The report compares Walgreens to other companies like CVS and Walmart, providing insights into the implications of such a change. Both reports provide valuable insights into the company’s performance and strategic direction, offering investors a comprehensive view of Walgreens Boots Alliance‘s position in the market.

A look at Walgreens Boots Alliance, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Walgreens Boots Alliance, Inc. is a retail drugstore that offers a wide range of prescription and non-prescription drugs, along with general goods. The company has received high scores in Value and Dividend, indicating a strong outlook in terms of its financial performance and dividend payouts. However, its scores in Growth, Resilience, and Momentum are lower, suggesting potential challenges in terms of future growth and market momentum.

Despite its strong financial position and dividend payouts, Walgreens Boots Alliance may face challenges in terms of growth, resilience, and momentum, as indicated by its lower scores in these areas. The company operates retail drugstores and offers various health services, including primary and acute care, wellness, pharmacy, and disease management services. Investors may want to consider these factors when assessing the long-term outlook for Walgreens Boots Alliance.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma